The aging immune system and its relationship with cancer

Papers of special note have been highlighted as: • of interest •• of considerable interest

Bibliography

• 1  Fulop T, Kotb R, Fortin CF, Pawelec G, De Angelis F, Larbi A. Potential role of immunosenescence in cancer development. Ann. NY Acad. Sci.1197,158–165 (2010).
  Medline CASGoogle Scholar
• 2  Hakim FT, Flomerfelt FA, Boyiadzis M, Gress RE. Aging, immunity and cancer. Curr. Opin. Immunol.16(2),151–156 (2004).
  Medline CASGoogle Scholar
• 3  Hakim FT, Gress RE. Immunosenescence: deficits in adaptive immunity in the elderly. Tissue Antigens70(3),179–189 (2007).
  Medline CASGoogle Scholar
• 4  Sportès C, Hakim FT. Aging, immunity and cancer. In: Handbook on Immunosenescence: Basic Understanding and Clinical Applications. Fulop T, Franceschi C, Hirokawa K, Pawelec G (Eds). Springer, Berlin, Germany (2009).
  Google Scholar
• 5  Schultzel M, Saltzstein SL, Downs TM, Shimasaki S, Sanders C, Sadler GR. Late age (85 years or older) peak incidence of bladder cancer. J. Urol.179(4),1302–1305; discussion 1305–1306 (2008).
  MedlineGoogle Scholar
• 6  Candore G, Balistreri CR, Listi F et al. Immunogenetics, gender, and longevity. Ann. NY Acad. Sci.1089,516–537 (2006).
  MedlineGoogle Scholar
• 7  Derhovanessian E, Maier AB, Beck R et al. Hallmark features of immunosenescence are absent in familial longevity. J. Immunol.185(8),4618–4624 (2010).
  Medline CASGoogle Scholar
• 8  Arranz L, Caamano JH, Lord JM, De la Fuente M. Preserved immune functions and controlled leukocyte oxidative stress in naturally long-lived mice: possible role of nuclear factor κB. J. Gerontol. A Biol. Sci. Med. Sci.65(9),941–950 (2010).
  MedlineGoogle Scholar
• 9  Arranz L, Lord JM, De la Fuente M. Preserved ex vivo inflammatory status and cytokine responses in naturally long-lived mice. Age (Dordr.)32(4),451–466 (2010).
  Medline CASGoogle Scholar
• 10  Schreiber TH, Podack ER. A critical analysis of the tumour immunosurveillance controversy for 3-MCA-induced sarcomas. Br. J. Cancer101(3),381–386 (2009).
  Medline CASGoogle Scholar
• 11  Bedel R, Thiery-Vuillemin A, Grandclement C et al. Novel role for STAT3 in transcriptional regulation of NK immune cell targeting receptor MICA on cancer cells. Cancer Res.71(5),1615–1626 (2011).
  Medline CASGoogle Scholar
• 12  Ridge JP, Di Rosa F, Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4⁺ T-helper and a T-killer cell. Nature393(6684),474–478 (1998).
  Medline CASGoogle Scholar
• 13  Bourgeois C, Rocha B, Tanchot C. A role for CD40 expression on CD8⁺ T cells in the generation of CD8⁺ T cell memory. Science297(5589),2060–2063 (2002).
  Medline CASGoogle Scholar
• 14  Matsui S, Ahlers JD, Vortmeyer AO et al. A model for CD8⁺ CTL tumor immunosurveillance and regulation of tumor escape by CD4 T cells through an effect on quality of CTL. J. Immunol.163(1),184–193 (1999).
  Medline CASGoogle Scholar
• 15  Gerner MY, Casey KA, Mescher MF. Defective MHC class II presentation by dendritic cells limits CD4 T cell help for antitumor CD8 T cell responses. J. Immunol.181(1),155–164 (2008).
  Medline CASGoogle Scholar
• 16  Corthay A, Skovseth DK, Lundin KU et al. Primary antitumor immune response mediated by CD4⁺ T cells. Immunity22(3),371–383 (2005).
  Medline CASGoogle Scholar
• 17  Corthay A, Lundin KU, Lorvik KB, Hofgaard PO, Bogen B. Secretion of tumor-specific antigen by myeloma cells is required for cancer immunosurveillance by CD4⁺ T cells. Cancer Res.69(14),5901–5907 (2009).
  Medline CASGoogle Scholar
• 18  Levitsky HI, Lazenby A, Hayashi RJ, Pardoll DM. In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression. J. Exp. Med.179(4),1215–1224 (1994).
  Medline CASGoogle Scholar
• 19  Bogen B, Munthe L, Sollien A et al. Naive CD4⁺ T cells confer idiotype-specific tumor resistance in the absence of antibodies. Eur. J. Immunol.25(11),3079–3086 (1995).
  Medline CASGoogle Scholar
• 20  Haabeth OA, Lorvik KB, Hammarstrom C et al. Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer. Nat. Comm.2,240 (2011).
  MedlineGoogle Scholar
• 21  Nakamura H, Saji H, Ogata A et al. Immunologic parameters as significant prognostic factors in lung cancer. Lung Cancer37(2),161–169 (2002).
  MedlineGoogle Scholar
• 22  Unitt E, Marshall A, Gelson W et al. Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation. J. Hepatol.45(2),246–253 (2006).
  Medline CASGoogle Scholar
• 23  Vella LA, Yu M, Fuhrmann SR, El-Amine M, Epperson DE, Finn OJ. Healthy individuals have T-cell and antibody responses to the tumor antigen cyclin B1 that when elicited in mice protect from cancer. Proc. Natl Acad. Sci. USA106(33),14010–14015 (2009).
  Medline CASGoogle Scholar
• 24  Koebel CM, Vermi W, Swann JB et al. Adaptive immunity maintains occult cancer in an equilibrium state. Nature450(7171),903–907 (2007).
  Medline CASGoogle Scholar
• 25  Engel AM, Svane IM, Rygaard J, Werdelin O. MCA sarcomas induced in SCID mice are more immunogenic than MCA sarcomas induced in congenic, immunocompetent mice. Scand. J. Immunol.45(5),463–470 (1997).
  Medline CASGoogle Scholar
• 26  Shankaran V, Ikeda H, Bruce AT et al. IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature410(6832),1107–1111 (2001).
  Medline CASGoogle Scholar
• 27  Haynes BF, Markert ML, Sempowski GD, Patel DD, Hale LP. The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. Ann. Rev. Immunol.18,529–560 (2000).
  Medline CASGoogle Scholar
• 28  Seddon B, Tomlinson P, Zamoyska R. Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells. Nat. Immunol.4(7),680–686 (2003).
  Medline CASGoogle Scholar
• 29  Surh CD, Boyman O, Purton JF, Sprent J. Homeostasis of memory T cells. Immunol. Rev.211,154–163 (2006).
  Medline CASGoogle Scholar
• 30  Ivory K, Martin R, Hughes DA. Significant presence of terminally differentiated T cells and altered NF-κB and I-κBα interactions in healthy ageing. Exp. Gerontol.39(4),567–576 (2004).
  Medline CASGoogle Scholar
• 31  Ouyang Q, Wagner WM, Wikby A et al. Large numbers of dysfunctional CD8⁺ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old. J. Clin. Immunol.23(4),247–257 (2003).
  Medline CASGoogle Scholar
• 32  Arnold CR, Wolf J, Brunner S, Herndler-Brandstetter D, Grubeck-Loebenstein B. Gain and loss of T cell subsets in old age – age-related reshaping of the T cell repertoire. J. Clin. Immunol.31(2),137–146 (2011).
  MedlineGoogle Scholar
• 33  Sempowski GD, Gooding ME, Liao HX, Le PT, Haynes BF. T cell receptor excision circle assessment of thymopoiesis in aging mice. Mol. Immunol.38(11),841–848 (2001).
  Google Scholar
• 34  Kilpatrick RD, Rickabaugh T, Hultin LE et al. Homeostasis of the naive CD4⁺ T cell compartment during aging. J. Immunol.180(3),1499–1507 (2008).
  Medline CASGoogle Scholar
• 35  Globerson A, Effros RB. Ageing of lymphocytes and lymphocytes in the aged. Immunol. Today21(10),515–521 (2000).
  Medline CASGoogle Scholar
• 36  Bouree P. Immunity and immunization in elderly. Pathol. Biol. (Paris)51(10),581–585 (2003).
  MedlineGoogle Scholar
• 37  Kang I, Hong MS, Nolasco H et al. Age-associated change in the frequency of memory CD4⁺ T cells impairs long term CD4⁺ T cell responses to influenza vaccine. J. Immunol.173(1),673–681 (2004).
  Medline CASGoogle Scholar
• 38  Eaton SM, Burns EM, Kusser K, Randall TD, Haynes L. Age-related defects in CD4 T cell cognate helper function lead to reductions in humoral responses. J. Exp. Med.200(12),1613–1622 (2004).
  Medline CASGoogle Scholar
• 39  Haynes L, Linton PJ, Eaton SM, Tonkonogy SL, Swain SL. Interleukin 2, but not other common γ chain-binding cytokines, can reverse the defect in generation of CD4 effector T cells from naive T cells of aged mice. J. Exp. Med.190(7),1013–1024 (1999).
  Medline CASGoogle Scholar
• 40  Eaton SM, Maue AC, Swain SL, Haynes L. Bone marrow precursor cells from aged mice generate CD4 T cells that function well in primary and memory responses. J. Immunol.181(7),4825–4831 (2008).•• Demonstrates that memory T cells formed from aged bone marrow precursor cells transferred into young hosts function normally. This supports T-cell-extrinsic factors in age-associated dysfunction.
  Medline CASGoogle Scholar
• 41  Yehuda AB, Friedman G, Wirtheim E, Abel L, Globerson A. Checkpoints in thymocytopoiesis in aging: expression of the recombination activating genes RAG-1 and RAG-2. Mech. Ageing Dev.102(2–3),239–247 (1998).
  Medline CASGoogle Scholar
• 42  Tsukamoto H, Clise-Dwyer K, Huston GE et al. Age-associated increase in lifespan of naive CD4 T cells contributes to T-cell homeostasis but facilitates development of functional defects. Proc. Natl Acad. Sci. USA106(43),18333–18338 (2009).
  Medline CASGoogle Scholar
• 43  Jones SC, Clise-Dwyer K, Huston G et al. Impact of post-thymic cellular longevity on the development of age-associated CD4⁺ T cell defects. J. Immunol.180(7),4465–4475 (2008).
  Medline CASGoogle Scholar
• 44  Tsukamoto H, Huston GE, Dibble J, Duso DK, Swain SL. Bim dictates naive CD4 T cell lifespan and the development of age-associated functional defects. J. Immunol.185(8),4535–4544 (2010).• Identified reduced BIM expression as being responsible for prolonged survival of aged naive CD4 T cells.
  Medline CASGoogle Scholar
• 45  Gui J, Zhu X, Dohkan J, Cheng L, Barnes PF, Su DM. The aged thymus shows normal recruitment of lymphohematopoietic progenitors but has defects in thymic epithelial cells. Int. Immunol.19(10),1201–1211 (2007).
  Medline CASGoogle Scholar
• 46  Zhu X, Gui J, Dohkan J, Cheng L, Barnes PF, Su DM. Lymphohematopoietic progenitors do not have a synchronized defect with age-related thymic involution. Aging Cell6(5),663–672 (2007).
  Medline CASGoogle Scholar
• 47  Sun L, Guo J, Brown R, Amagai T, Zhao Y, Su DM. Declining expression of a single epithelial cell-autonomous gene accelerates age-related thymic involution. Aging Cell9(3),347–357 (2010).• Identified declining FoxN1 expression as a critical mediator of thymic epithelial cell degeneration.
  Medline CASGoogle Scholar
• 48  Sauce D, Larsen M, Fastenackels S et al. Evidence of premature immune aging in patients thymectomized during early childhood. J. Clin. Invest.119(10),3070–3078 (2009).• Demonstrates accelerated aging of the immune system in individuals thymectomized at an early age.
  Medline CASGoogle Scholar
• 49  Madhok AB, Chandrasekran A, Parnell V, Gandhi M, Chowdhury D, Pahwa S. Levels of recent thymic emigrant cells decrease in children undergoing partial thymectomy during cardiac surgery. Clin. Diagn. Lab. Immunol.12(5),563–565 (2005).
  Medline CASGoogle Scholar
• 50  Ogle BM, West LJ, Driscoll DJ et al. Effacing of the T cell compartment by cardiac transplantation in infancy. J. Immunol.176(3),1962–1967 (2006).
  Medline CASGoogle Scholar
• 51  Ahmed M, Lanzer KG, Yager EJ, Adams PS, Johnson LL, Blackman MA. Clonal expansions and loss of receptor diversity in the naive CD8 T cell repertoire of aged mice. J. Immunol.182(2),784–792 (2009).
  Medline CASGoogle Scholar
• 52  Czesnikiewicz-Guzik M, Lee WW, Cui D et al. T cell subset-specific susceptibility to aging. Clin. Immunol.127(1),107–118 (2008).
  Medline CASGoogle Scholar
• 53  Gupta S, Gollapudi S. TNF-α-induced apoptosis in human naive and memory CD8⁺ T cells in aged humans. Exp. Gerontol.41(1),69–77 (2006).
  Medline CASGoogle Scholar
• 54  Gupta S, Gollapudi S. CD95-mediated apoptosis in naive, central and effector memory subsets of CD4⁺ and CD8⁺ T cells in aged humans. Exp. Gerontol.43(4),266–274 (2008).
  Medline CASGoogle Scholar
• 55  Smithey MJ, Renkema KR, Rudd BD, Nikolich-Zugich J. Increased apoptosis, curtailed expansion and incomplete differentiation of CD8⁺ T cells combine to decrease clearance of L. monocytogenes in old mice. Eur. J. Immunol.41(5),1352–1364 (2011).
  Medline CASGoogle Scholar
• 56  Cicin-Sain L, Smyk-Pearson S, Currier N et al. Loss of naive T cells and repertoire constriction predict poor response to vaccination in old primates. J. Immunol.184(12),6739–6745 (2010).
  Medline CASGoogle Scholar
• 57  Linton PJ, Li SP, Zhang Y, Bautista B, Huynh Q, Trinh T. Intrinsic versus environmental influences on T-cell responses in aging. Immunol. Rev.205,207–219 (2005).
  Medline CASGoogle Scholar
• 58  Cusi MG, Martorelli B, Di Genova G, Terrosi C, Campoccia G, Correale P. Age related changes in T cell mediated immune response and effector memory to respiratory syncytial virus (RSV) in healthy subjects. Immun. Ageing7,14 (2010).
  MedlineGoogle Scholar
• 59  Watanabe MA, Oda JM, Amarante MK, Cesar Voltarelli J. Regulatory T cells and breast cancer: implications for immunopathogenesis. Cancer Metastasis Rev.29(4),569–579 (2010).
  Medline CASGoogle Scholar
• 60  Hirokawa K, Utsuyama M, Ishikawa T et al. Decline of T cell-related immune functions in cancer patients and an attempt to restore them through infusion of activated autologous T cells. Mech. Ageing Dev.130(1–2),86–91 (2009).
  Medline CASGoogle Scholar
• 61  Rottinghaus EK, Vesosky B, Turner J. Interleukin-12 is sufficient to promote antigen-independent interferon-γ production by CD8 T cells in old mice. Immunology128(Suppl. 1),e679–e690 (2009).
  MedlineGoogle Scholar
• 62  Ouyang X, Yang Z, Zhang R et al. Potentiation of Th17 cytokines in aging process contributes to the development of colitis. Cell Immunol.266(2),208–217 (2011).
  Medline CASGoogle Scholar
• 63  Wang L, Yi T, Zhang W, Pardoll DM, Yu H. IL-17 enhances tumor development in carcinogen-induced skin cancer. Cancer Res.70(24),10112–10120 (2010).
  Medline CASGoogle Scholar
• 64  Iida T, Iwahashi M, Katsuda M et al. Tumor-infiltrating CD4⁺ Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer. Oncol. Rep.25(5),1271–1277 (2011).
  Medline CASGoogle Scholar
• 65  Wilke CM, Kryczek I, Wei S et al. Th17 cells in cancer: help or hindrance? Carcinogenesis32(5),643–649 (2011).
  Medline CASGoogle Scholar
• 66  Ahmad A, Banerjee S, Wang Z, Kong D, Majumdar AP, Sarkar FH. Aging and inflammation: etiological culprits of cancer. Curr. Aging Sci.2(3),174–186 (2009).
  Medline CASGoogle Scholar
• 67  Haynes L, Maue AC. Effects of aging on T cell function. Curr. Opin. Immunol.21(4),414–417 (2009).
  Medline CASGoogle Scholar
• 68  Maue AC, Yager EJ, Swain SL, Woodland DL, Blackman MA, Haynes L. T-cell immunosenescence: lessons learned from mouse models of aging. Trends Immunol.30(7),301–305 (2009).
  Medline CASGoogle Scholar
• 69  Yager EJ, Ahmed M, Lanzer K, Randall TD, Woodland DL, Blackman MA. Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus. J. Exp. Med.205(3),711–723 (2008).
  Medline CASGoogle Scholar
• 70  Parish ST, Wu JE, Effros RB. Sustained CD28 expression delays multiple features of replicative senescence in human CD8 T lymphocytes. J. Clin. Immunol.30(6),798–805 (2010).
  Medline CASGoogle Scholar
• 71  Effros RB. Telomere/telomerase dynamics within the human immune system: effect of chronic infection and stress. Exp. Gerontol.46(2–3),135–140 (2010).• Highlights recent findings in the T lymphocyte replicative senescence model, the role of latent viral infections and also addresses therapeutic approaches to retarding the process of senescence.
  MedlineGoogle Scholar
• 72  Cortesini R, Lemaoult J, Ciubotariu R, Cortesini NS. CD8⁺CD28^- T suppressor cells and the induction of antigen-specific, antigen-presenting cell-mediated suppression of Th reactivity. Immunol. Rev.182,201–206 (2001).
  Medline CASGoogle Scholar
• 73  Parish ST, Kim S, Sekhon RK, Wu JE, Kawakatsu Y, Effros RB. Adenosine deaminase modulation of telomerase activity and replicative senescence in human CD8 T lymphocytes. J. Immunol.184(6),2847–2854 (2010).
  Medline CASGoogle Scholar
• 74  Mackenzie WM, Hoskin DW, Blay J. Adenosine suppresses α(4)β(7) integrin-mediated adhesion of T lymphocytes to colon adenocarcinoma cells. Exp. Cell Res.276(1),90–100 (2002).
  Medline CASGoogle Scholar
• 75  Plunkett FJ, Franzese O, Finney HM et al. The loss of telomerase activity in highly differentiated CD8⁺CD28^-CD27^- T cells is associated with decreased Akt (Ser473) phosphorylation. J. Immunol.178(12),7710–7719 (2007).
  Medline CASGoogle Scholar
• 76  Meloni F, Morosini M, Solari N et al. Foxp3 expressing CD4⁺ CD25⁺ and CD8⁺CD28^- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. Hum. Immunol.67(1–2),1–12 (2006).
  Medline CASGoogle Scholar
• 77  Tsukishiro T, Donnenberg AD, Whiteside TL. Rapid turnover of the CD8⁺CD28^- T-cell subset of effector cells in the circulation of patients with head and neck cancer. Cancer Immunol. Immunother.52(10),599–607 (2003).
  MedlineGoogle Scholar
• 78  Chang WC, Li CH, Huang SC, Chang DY, Chou LY, Sheu BC. Clinical significance of regulatory T cells and CD8⁺ effector populations in patients with human endometrial carcinoma. Cancer116(24),5777–5788 (2010).
  Medline CASGoogle Scholar
• 79  Urbaniak-Kujda D, Kapelko-Slowik K, Wolowiec D et al. Increased percentage of CD8⁺CD28^- suppressor lymphocytes in peripheral blood and skin infiltrates correlates with advanced disease in patients with cutaneous T-cell lymphomas. Postepy. Hig. Med. Dosw. (Online)63,355–359 (2009).
  MedlineGoogle Scholar
• 80  Kruger K, Buning C, Schriever F. Activated T lymphocytes bind in situ to stromal tissue of colon carcinoma but lack adhesion to tumor cells. Eur. J. Immunol.31(1),138–145 (2001).
  Medline CASGoogle Scholar
• 81  Becker JC, Vetter CS, Schrama D, Bröcker EB, thor Straten P. Differential expression of CD28 and CD94/NKG2 on T cells with identical TCR β variable regions in primary melanoma and sentinel lymph node. Eur. J. Immunol.30(12),3699–3706 (2000).
  Medline CASGoogle Scholar
• 82  Characiejus D, Pasukoniene V, Kazlauskaite N et al. Predictive value of CD8^highCD57⁺ lymphocyte subset in interferon therapy of patients with renal cell carcinoma. Anticancer Res.22(6B),3679–3683 (2002).
  MedlineGoogle Scholar
• 83  Characiejus D, Pasukoniene V, Jacobs JJ et al. Prognostic significance of peripheral blood CD8^highCD57⁺ lymphocytes in bladder carcinoma patients after intravesical IL-2. Anticancer Res.31(2),699–703 (2011).
  Medline CASGoogle Scholar
• 84  Malaguarnera L, Cristaldi E, Malaguarnera M. The role of immunity in elderly cancer. Crit. Rev. Oncol. Hematol.74(1),40–60 (2010).
  MedlineGoogle Scholar
• 85  Diak P, Siegel J, La Grenade L, Choi L, Lemery S, McMahon A. Tumor necrosis factor α blockers and malignancy in children: forty-eight cases reported to the food and drug administration. Arthritis Rheum.62(8),2517–2524 (2010).
  MedlineGoogle Scholar
• 86  Zidi I, Mestiri S, Bartegi A, Amor NB. TNF-α and its inhibitors in cancer. Med. Oncol.27(2),185–198 (2009).
  MedlineGoogle Scholar
• 87  Begley LA, Kasina S, MacDonald J, Macoska JA. The inflammatory microenvironment of the aging prostate facilitates cellular proliferation and hypertrophy. Cytokine43(2),194–199 (2008).
  Medline CASGoogle Scholar
• 88  Barron DA, Strand DW, Ressler SJ et al. TGF-β1 induces an age-dependent inflammation of nerve ganglia and fibroplasia in the prostate gland stroma of a novel transgenic mouse. PLoS One5(10),e13751 (2010).
  MedlineGoogle Scholar
• 89  Bianchi-Frias D, Vakar-Lopez F, Coleman IM, Plymate SR, Reed MJ, Nelson PS. The effects of aging on the molecular and cellular composition of the prostate microenvironment. PLoS One5(9),e12501 (2010).
  MedlineGoogle Scholar
• 90  McDowell KL, Begley LA, Mor-Vaknin N, Markovitz DM, Macoska JA. Leukocytic promotion of prostate cellular proliferation. Prostate70(4),377–389 (2010).
  Medline CASGoogle Scholar
• 91  Anderson MJ, Shafer-Weaver K, Greenberg NM, Hurwitz AA. Tolerization of tumor-specific T cells despite efficient initial priming in a primary murine model of prostate cancer. J. Immunol.178(3),1268–1276 (2007).
  Medline CASGoogle Scholar
• 92  Szajnik M, Czystowska M, Szczepanski MJ, Mandapathil M, Whiteside TL. Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (T ). PLoS One5(7),e11469 (2010).
  MedlineGoogle Scholar
• 93  Fry TJ, Sinha M, Milliron M et al. Flt3 ligand enhances thymic-dependent and thymic-independent immune reconstitution. Blood104(9),2794–2800 (2004).
  Medline CASGoogle Scholar
• 101  National Cancer Institute website. Surveillance, Epidemiology and End Results (SEER) database http://seer.cancer.gov/
  Google Scholar